XML 89 R71.htm IDEA: XBRL DOCUMENT v3.25.0.1
Stockholders’ Equity - Estimated Grant-Date Fair Value (Details) - $ / shares
12 Months Ended
Jan. 03, 2025
Dec. 29, 2023
Dec. 30, 2022
Dec. 31, 2021
TSR-Based Restricted Stock Units        
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]        
Weighted average grant date fair value, awarded (in dollars per share) $ 20.19 $ 26.05    
Fair value of Exelixis common stock on grant date (in dollars per share) $ 21.71 $ 19.48 $ 20.70  
Expected volatility 36.68% 40.26% 46.85%  
Risk-free interest rate 4.42% 3.75% 1.59%  
Dividend yield 0.00% 0.00% 0.00%  
Performance stock units        
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]        
Weighted average grant date fair value, awarded (in dollars per share) $ 24.54   $ 33.17 $ 24.54
Fair value of Exelixis common stock on grant date (in dollars per share)       $ 21.31
Expected volatility       49.21%
Risk-free interest rate       0.29%
Dividend yield       0.00%